Atrophy: Clinical Trials

11 trials for Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 unknown. 11 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Unknown 11
Phase 32Unknown 2

Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Whole Grain Job's Tear, Muscle Health, Blood Glucose and Lipid Level
Taiwanese whole grain job's tear (red job's tear), White job's tear - Sarcopenia, Frailty
Phase 2UnknownTaipei Veterans General Hospital, Taiwan802024-06-142024-07-16
Nutritional Therapy in Late-onset Pompe Disease
Multi-ingredient supplement (PDT-MIS), Placebo (PLA) - Pompe Disease, Muscle Loss
Phase 2UnknownMcMaster University282024-04-012023-11-14
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery
Phase 2 / Phase 3UnknownThe Stone Research Foundation for Sports Medicine and Arthritis152020-05-082021-08-31
Effects of Exercise During the Acute Phase of Burns
Exercise, Standard of Care - Burns
Phase 2UnknownUniversiteit Antwerpen402020-05-042020-08-14
Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury
Nerve Growth Factor, Edaravone, Combination of vitamin B1, B6, C, E and mecobalamine - Alcohol-induced Brain Injury
Phase 2UnknownSun Yat-Sen Memorial Hospital of Sun Yat-Sen University1502019-06-302020-10-27
Effect of Melatonin on Cardiovascular and Muscle Mass and Function in Patients With Heart Failure
Melatonin 10 mg, Placebo Oral Tablet - Heart Failure With Reduced Ejection Fraction
Phase 2UnknownIsfahan University of Medical Sciences902018-11-302019-03-28
A Study to Investigate the Effect of HMB on Skeletal Muscle Wasting in Early Critical Illness
HMB, Lactose (placebo) - Critical Illness
Phase 2UnknownGuy's and St Thomas' NHS Foundation Trust682018-06-182021-03-17
Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males
Creatine monohydrate, Maltodextrin Powder - Sarcopenia
Phase 2UnknownUniversity of Regina402018-01-012018-05-21
Bone Changes in Atrophic Maxilla Treated by Split-crest Technique
Ridge splitting, immediate implant, Nanobone with PRF., Ridge splitting, immediate implantand PRF. - Atrophy; Edentulous Ridge
Phase 2 / Phase 3UnknownCairo University402017-01-012017-01-16
A Study Comparing Chemotherapy Dosing Based on Either Standard Body Surface Area or Lean Body Mass in Patients With Advanced Lung Cancer
Standard dosing method arm: Cisplatin (chemotherapy) dosing based on body surface area, Experimental dosing method arm: Cisplatin (chemotherapy) dosing based on individual lean body mass - Lung Cancer
Phase 2UnknownAHS Cancer Control Alberta1442014-07-012014-09-30
Exercise For Sub-acute Stroke Patients in Jamaica
Task Oriented Exercise Training, Stroke Care "Get with the Guidelines" - Stroke
Phase 2UnknownBaltimore VA Medical Center1502011-07-012016-11-01

Narrower conditions

Muscular Atrophy (6)  ·  Sarcopenia (3)  ·  Insulin Resistance (2)  ·  Burns (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Critical Illness (1)  ·  Demyelinating Diseases (1)  ·  Disease (1)  ·  Frailty (1)  ·  Glycogen Storage Disease Type II (1)  ·  Heart Failure (1)  ·  Hyperglycemia (1)  ·  Hyperlipidemias (1)  ·  Inflammation (1)

Broader conditions

Pathological Conditions, Anatomical (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Nervous System Diseases (10)  ·  Neurologic Manifestations (9)  ·  Neuromuscular Manifestations (9)  ·  Signs and Symptoms (9)  ·  Metabolic Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Pathologic Processes (4)  ·  Glucose Metabolism Disorders (3)  ·  Muscular Atrophy (3)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)

Interventions

Creatine (1)  ·  Drug Therapy (1)  ·  Edaravone (1)  ·  Exercise (1)  ·  Injections, Intramuscular (1)  ·  Lactose (1)  ·  Melatonin (1)  ·  NanoBone (1)  ·  Nerve Growth Factor (1)  ·  Prolactin-Releasing Hormone (1)  ·  Saline Solution (1)  ·  Standard of Care (1)  ·  Testosterone Propionate (1)  ·  beta-hydroxyisovaleric acid (1)

Sponsors

AHS Cancer Control Alberta (1)  ·  Baltimore VA Medical Center (1)  ·  Cairo University (1)  ·  Guy's and St Thomas' NHS Foundation Trust (1)  ·  Isfahan University of Medical Sciences (1)  ·  McMaster University (1)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  The Stone Research Foundation for Sports Medicine and Arthritis (1)  ·  Universiteit Antwerpen (1)  ·  University of Regina (1)

Countries

Canada (2)  ·  United States (2)  ·  Belgium (1)  ·  China (1)  ·  Iran (1)  ·  Jamaica (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Ahmed Reda, Lecturer (1)  ·  Amr Zahran, Professor (1)  ·  Anchun Hwang, Doctor (1)  ·  Darren G Candow, PhD (1)  ·  Mani Vessal, Ph.D. (1)  ·  Mark Tarnopololsky, MD/PhD (1)  ·  Masoumeh Sadeghi, MD (1)  ·  Michael B Sawyer, MD (1)  ·  Nicholas Hart (1)  ·  Richard F Macko, MD (1)  ·  Terrence Forrester, MD (1)  ·  Ulrike Van Daele (1)  ·  Vickie Baracos, PhD (1)

Results publications

PMID 38049955, PMID 38877464

NIH funding

2016 (1), R01HD068712 (1)